Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-25 5:25 pm Unchanged | 13D | SCILEX HLDG CO COM SCLX | SCLX Stock Acquisition JV LLC | 89,616,299 33.3% | 0 (Unchanged) | View |
| 2024-03-05 4:22 pm Unchanged | 13D | SCILEX HLDG CO COM SCLX | SCLX Stock Acquisition JV LLC | 89,616,299 36.4% | 0 (Unchanged) | View |
| 2024-01-31 5:24 pm Unchanged | 13D | SCILEX HLDG CO COM SCLX | SCLX Stock Acquisition JV LLC | 89,616,299 38.2% | 0 (Unchanged) | View |
| 2023-09-29 4:15 pm Purchase | 13D | SCILEX HLDG CO COM SCLX | SCLX Stock Acquisition JV LLC | 89,616,299 39.3% | 89,616,299 (New Position) | View |
| 2023-09-26 4:49 pm Sale | 13D | SCILEX HLDG CO COM SCLX | Sorrento Therapeutics Inc. SRNEQ | 1,917,210 1.3% | -93,616,299 (-97.99%) | View |
| 2023-08-14 8:59 pm Unchanged | 13D | SCILEX HLDG CO COM SCLX | Sorrento Therapeutics Inc. SRNEQ | 95,533,509 43.3% | 0 (Unchanged) | View |
| 2023-03-03 09:10 am Unchanged | 13D | SCILEX HLDG CO COM SCLX | Sorrento Therapeutics Inc. SRNEQ | 95,533,509 44.2% | 0 (Unchanged) | View |
| 2023-02-13 1:52 pm Unchanged | 13G | SCILEX HLDG CO COM SCLX | Hudson Bay Capital Management LP | 0 0% | 0 (Unchanged) | View |
| 2023-01-23 4:33 pm Sale | 13D | SCILEX HLDG CO COM SCLX | Sorrento Therapeutics Inc. SRNEQ | 95,533,509 45.5% | -72,354,178 (-43.10%) | View |
| 2022-12-09 4:21 pm Sale | 13G | VICKERS VANTAGE CORP I SHS VCKA | Karpus Management Inc. | 0 0% | -1,737,145 (Position Closed) | View |
| 2022-11-17 5:09 pm Purchase | 13D | SCILEX HLDG CO COM SCLX | Sorrento Therapeutics Inc. SRNEQ | 167,887,687 96.3% | 167,887,687 (New Position) | View |
| 2022-11-14 09:14 am Sale | 13G | VICKERS VANTAGE CORP I SHS VCKA | Feis Lawrence | 0 0% | -753,037 (Position Closed) | View |
| 2022-07-27 3:33 pm Purchase | 13G | VICKERS VANTAGE CORP I SHS VCKA | Feis Lawrence | 753,037 5.72% | 753,037 (New Position) | View |
| 2022-02-14 3:28 pm Purchase | 13G | VICKERS VANTAGE CORP I SHS VCKA | CVI Investments Inc. | 749,600 4.3% | 749,600 (New Position) | View |
| 2022-02-11 2:19 pm Purchase | 13G | VICKERS VANTAGE CORP I SHS VCKA | Shaolin Capital Management LLC | 1,325,779 7.7% | 1,325,779 (New Position) | View |
| 2022-02-03 4:55 pm Purchase | 13G | VICKERS VANTAGE CORP I SHS VCKA | Hudson Bay Capital Management LP | 900,500 5.22% | 900,500 (New Position) | View |
| 2022-02-02 2:25 pm Sale | 13G | VICKERS VANTAGE CORP I UNIT 1 VCKAU | Space Summit Capital LLC | 0 0% | -724,514 (Position Closed) | View |
| 2022-01-10 4:13 pm Purchase | 13G | VICKERS VANTAGE CORP I SHS VCKA | Karpus Management Inc. | 1,737,145 10.07% | 1,737,145 (New Position) | View |
| 2021-03-08 4:36 pm Purchase | 13G | VICKERS VANTAGE CORP I UNIT 1 VCKAU | Space Summit Capital LLC | 724,514 5.25% | 724,514 (New Position) | View |
| 2021-01-14 10:48 am Purchase | 13G | VICKERS VANTAGE CORP I UNIT 1 VCKAU | CVI Investments Inc. | 750,000 6.3% | 750,000 (New Position) | View |